Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Upcoming SlideShare
Loading in...5
×
 

Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma

on

  • 235 views

Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma ...

Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma


DISCLAIMER-

Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.

Statistics

Views

Total Views
235
Views on SlideShare
235
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

CC Attribution License

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma Document Transcript

  • National Cancer Institute at the National Institutes of Health Updated: 03/10/2014 Drugs Approved for Non-Hodgkin Lymphoma This page lists cancer drugs approved by the Food and Drug Administration (FDA) for non-Hodgkin lymphoma. The list includes generic and brand names. This page also lists common drug combinations used in non-Hodgkin lymphoma. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in non-Hodgkin lymphoma that are not listed here. Abitrexate (Methotrexate) Adcetris (Brentuximab Vedotin) Adriamycin PFS (Doxorubicin Hydrochloride) Adriamycin RDF (Doxorubicin Hydrochloride) Ambochlorin (Chlorambucil) Amboclorin (Chlorambucil) Arranon (Nelarabine) Bendamustine Hydrochloride Bexxar (Tositumomab and Iodine I 131 Tositumomab) Blenoxane (Bleomycin) Bleomycin Bortezomib Brentuximab Vedotin Chlorambucil Clafen (Cyclophosphamide) Cyclophosphamide Cytoxan (Cyclophosphamide) Denileukin Diftitox DepoCyt (Liposomal Cytarabine) Doxorubicin Hydrochloride DTIC-Dome (Dacarbazine) Folex (Methotrexate) Folex PFS (Methotrexate) Folotyn (Pralatrexate) Cancer Drug Information Drugs Approved for Non-Hodgkin Lymphoma - National Cancer Institute http://www.cancer.gov/cancertopics/druginfo/non-hodgkin/print 1 of 3 5/12/2014 3:56 AM
  • Ibritumomab Tiuxetan Ibrutinib Imbruvica (Ibrutinib) Intron A (Recombinant Interferon Alfa-2b) Istodax (Romidepsin) Lenalidomide Leukeran (Chlorambucil) Linfolizin (Chlorambucil) Liposomal Cytarabine Matulane (Procarbazine Hydrochloride) Methotrexate Methotrexate LPF (Methotrexate) Mexate (Methotrexate) Mexate-AQ (Methotrexate) Mozobil (Plerixafor) Nelarabine Neosar (Cyclophosphamide) Ontak (Denileukin Diftitox) Plerixafor Pralatrexate Recombinant Interferon Alfa-2b Revlimid (Lenalidomide) Rituxan (Rituximab) Rituximab Romidepsin Tositumomab and Iodine I 131 Tositumomab Treanda (Bendamustine Hydrochloride) Velban (Vinblastine Sulfate) Velcade (Bortezomib) Velsar (Vinblastine Sulfate) Vinblastine Sulfate Vincasar PFS (Vincristine Sulfate) Vincristine Sulfate Vorinostat Zevalin (Ibritumomab Tiuxetan) Zolinza (Vorinostat) Drug Combinations Used in Non-Hodgkin Lymphoma CHOP COPP CVP EPOCH Hyper-CVAD ICE Drugs Approved for Non-Hodgkin Lymphoma - National Cancer Institute http://www.cancer.gov/cancertopics/druginfo/non-hodgkin/print 2 of 3 5/12/2014 3:56 AM
  • R-CHOP Drugs Approved for Non-Hodgkin Lymphoma - National Cancer Institute http://www.cancer.gov/cancertopics/druginfo/non-hodgkin/print 3 of 3 5/12/2014 3:56 AM View slide